Literature DB >> 10222650

Cytokine signaling for proliferation, survival, and death in hematopoietic cells.

A Miyajima1, Y Ito, T Kinoshita.   

Abstract

The survival, proliferation, and differentiation of hematopoietic cells are regulated by cytokines. In the absence of cytokines, hematopoietic cells not only stop proliferation, but undergo apoptosis. This strict dependency of hematopoietic cells on cytokines is an important mechanism that maintains the homeostasis of blood cells. Cytokines induce various intracellular signaling pathways by activating the receptor-associated Janus kinases (Jaks), and distinct signals are responsible for cell cycle progression and cell survival. Induction of signals for cell cycle progression without suppressing apoptosis results in apoptotic cell death, indicating the essential role of anti-apoptotic signaling for cell growth. In hematopoietic cells, Ras, a cellular protooncogen product, and phosphatidylinositol 3 kinase are involved in the suppression of apoptosis. Cytokine depletion not only turns off anti-apoptotic signaling, but also actively induces cell death by activating caspases, a distinct family of cysteine proteases. Alterations in the mechanisms of cytokine signaling for cell cycle progression and anti-apoptotic function are implicated in hematological disorders.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222650

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

Review 1.  Cytokine-mediated cell survival.

Authors:  Toshiya Inaba
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

2.  Downregulation of Bim, a proapoptotic relative of Bcl-2, is a pivotal step in cytokine-initiated survival signaling in murine hematopoietic progenitors.

Authors:  T Shinjyo; R Kuribara; T Inukai; H Hosoi; T Kinoshita; A Miyajima; P J Houghton; A T Look; K Ozawa; T Inaba
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 3.  Ex vivo expansion of human hematopoietic stem cells.

Authors:  T Nakahata
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 4.  Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism.

Authors:  Akira Yuo
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

5.  Structure of the human Bim gene and its transcriptional regulation in Baf-3, interleukin-3-dependent hematopoietic cells.

Authors:  Hirotaka Matsui; Tetsuharu Shinjyo; Toshiya Inaba
Journal:  Mol Biol Rep       Date:  2005-06       Impact factor: 2.316

6.  Bomapin is a redox-sensitive nuclear serpin that affects responsiveness of myeloid progenitor cells to growth environment.

Authors:  Patrycja Przygodzka; Björn Ramstedt; Tobias Tengel; Göran Larsson; Malgorzata Wilczynska
Journal:  BMC Cell Biol       Date:  2010-04-30       Impact factor: 4.241

Review 7.  Bcr-Abl is a "molecular switch" for the decision for growth and differentiation in hematopoietic stem cells.

Authors:  Takumi Era
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

8.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

9.  Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors.

Authors:  Ryoko Kuribara; Hiroaki Honda; Hirotaka Matsui; Tetsuharu Shinjyo; Takeshi Inukai; Kanji Sugita; Shinpei Nakazawa; Hisamaru Hirai; Keiya Ozawa; Toshiya Inaba
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

10.  Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis.

Authors:  Hirohiko Shibayama; Emi Takai; Itaru Matsumura; Michiyoshi Kouno; Eiichi Morii; Yukihiko Kitamura; Junji Takeda; Yuzuru Kanakura
Journal:  J Exp Med       Date:  2004-02-16       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.